THE EFFECTS OF THE ALKYLATING CYTOSTATIC AGENT, 2,3,5-TRISETHYLENEIMINO-BENZOQUINONE-1,4(TRENIMON), ON THE PRIMING ABILITY OF DNA FROM MOUSE-ASCITES-TUMOR CELLS IN THE RNA-POLYMERASE-SYSTEM.
D000477:Alkylating Agents; D000818:Animals; D000970:Antineoplastic Agents; D001201:Ascites; D016227:Benzoquinones; D002286:Carcinoma, Ehrlich Tumor; D054697:Cytostatic Agents; D004247:DNA; D004273:DNA, Neoplasm; D012321:DNA-Directed RNA Polymerases; D008660:Metabolism; D051379:Mice; D009713:Nucleotidyltransferases; D010600:Pharmacology; D012313:RNA; D012334:RNA, Neoplasm; D012106:Research; D014228:Triaziquone
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D016227:Benzoquinones; D054697:Cytostatic Agents; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D012313:RNA; D004247:DNA; D009713:Nucleotidyltransferases; D012321:DNA-Directed RNA Polymerases; D014228:Triaziquone
ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; DNA, NEOPLASM; EXPERIMENTAL LAB STUDY; METABOLISM; NUCLEOTIDYLTRANSFERASES; PHARMACOLOGY; RNA, NEOPLASM; TRIAZIQUONE